Dr. Pakianathan is a Managing Member at Delphi Ventures, a venture capital firm focusing on healthcare investments. Prior to joining Delphi, Dr. Pakianathan served as a Vice President in the healthcare group at JP Morgan Chase & Company from 1998-2001. Before joining JP Morgan, Dr. Pakianathan served as a postdoctoral scientist in the Immunology Department at Genentech. Dr. Pakianathan currently serves on the board of directors of Alder Biopharmaceuticals, Alexza Pharmaceuticals, Karyopharm Therapeutics and OncoMed Pharmaceuticals. Dr. Pakianathan holds an M.S. and a Ph.D. from Wake Forest University, a B.Sc. from the University of Bombay, India and an M.Sc. from The Cancer Research Institute at the University of Bombay, India.